INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 451m ago
HOUSE PTR51m ago
SEC 13F51m ago
ROBINHOOD CHAIN51m ago
Corporate insider
AD

Anderson Woodrow D

Chief Accounting OfficerCIK 0002014440

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells1 / 0
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Open-market purchase
BUY$54K
1,500 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Indivior Pharmaceuticals, Inc.Chief Accounting Officer · Feb 12, 2026
21
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M
—
18.4K sh
Mar 3, 2026
Mar 5, 2026
traded Mar 3, 2026
+2d
SEC FORM 4

Evidence

9
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
24.0K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

27
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Tax withholding
F$265K
8,283 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

17
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
5,946 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

9
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
5,946 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

16
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Tax withholding
F$86K
2,682 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

21
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
6,903 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

15
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
24.0K sh
Feb 9, 2026Feb 12, 2026
traded Feb 9, 2026
+3dSEC FORM 4

Evidence